The Newcastle DEC is now known as the Newcastle IVD Co-operative.  
Our new website is currently under development. We will continue to update this one until it's ready! Please check back again soon!

The Newcastle MIC is one of 11 NIHR MedTech In vitro diagnostic Co-operatives (MICs) set up to build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially supplied in vitro diagnostic (IVD) tests.

The Newcastle IVD Co-operative is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.

The NIHR Newcastle MIC facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us

Newly funded NIHR Medtech and In vitro diagnostic Co-operatives announced

To coincide with the publication of the Life Science Industrial Strategy, Health Secretary Jeremy Hunt, announces £14.25 million funding to support 11 NIHR Medtech and In vitro diagnostic Co-operatives (MICs). 

News & Developments

Hold the date!

Diagnostics North East Conference 2018 

Supporting early stage development to clinical adoption

14th – 15th March 2018, International Centre for Life, Newcastle upon Tyne. This two day conference will showcase the diagnostic resources and expertise available to support researchers, clinicians, and industry in developing and deploying new and innovative diagnostic technologies. For priority access to registration when it opens please register your interest.

NIHR DEC Newcastle play key role in development of NICE Guideline

Familial hypercholesterolaemia: identification and management

Evidence reviews for case-finding, diagnosis and statin monotherapy

17/145 - NIHR Efficacy and Mechanism Evaluation (EME) Programme researcher-led will fund ambitious studies evaluating interventions that have the potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. The deadline for applications is 1pm, 27 March 2018

17/136 - NIHR Health Technology Assessment (HTA) Programme - Sepsis. Invites proposals for the evaluation of interventions to improve the identification, diagnosis and management of sepsis. Deadline for  stage 1 applications is 1pm, 28 March 2018 

Biomedical Catalyst 2017 round 4: primer and late stage awards support the development of innovative healthcare products, technologies and processes. Closes Wednesday 7 February 2018 12:00pm. 

Are you set for the Medical Devices Regulations?

Read here for more information and see the following BSI report

£££ See here for recent funding opportunities £££ 

The DEC is funded by the NIHR